ACIP voted to recommend against anyone — adult, child and pregnant person — receiving a seasonal flu vaccine with the mercury ...

The letter, signed by 79 medical societies, expresses concern over recent federal immunization review policies and asks that ...

The first bacteria our bodies meet – in the hours after we're born – could protect us from dangerous infections, UK scientists say. They have shown, for the first time, that good bacteria seem to ...

Of 695 RSV-infected infants, 545 full-length RSV genome sequences were analysed, with 260 (48%) from nirsevimab-treated breakthrough infections and 285 (52%) from untreated infants. RSV-A was the ...

RSV patients treated with antiviral drug S-337395 showed statistically significant reduction in viral load S-337395 is generally safe and well tolerated with no serious adverse events reported in ...

Sanofi executives also pointed to the company’s new RSV vaccine for newborns, Beyfortus, approved by the FDA in mid-2023. Last year, the vaccine brought in €1.7 billion ($1.77 billion) in 2024.

Since the COVID-19 pandemic, genomic surveillance for the pneumoviruses human respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) has increased substantially worldwide (appendix). In a ...

Severe respiratory syncytial virus (RSV) disease is a significant contributor to the global burden of disease in infants and children. The RSV attachment protein (G) has been shown to be critical in ...

These trends were similar with those observed in other US regions in a repeated phylogenetic analysis comprising publicly available whole-genome sequencing data. Relative to all publicly available RSV ...